Also in this playlist...
This transcript is automatically generated
One of the most controversial components of modern health care research stem cells.
And while the jury is out on how or -- use embryonic stem cells to treat cancer heart disease and other diseases several companies are now turning our attention.
And you invest -- money.
Two adult stem cells joining me now any fox -- explosive interview doctor Robyn Smith she's the chairman and CEO.
Bio pharmaceutical firm.
Neo sand based in New York doctor -- to have you -- -- let's talk about the confusion in particular foremost about stem cell research we've had celebrities Michael J.
Fox for instance.
A former First Lady Nancy Reagan testifying.
23 years ago about embryonic stem cell research that has gotten the media's attention.
Has not changed how do you differentiate to the to the public the different -- adult stem cells and embryonic stem.
I will they're different sources of stem cells you can get it from an embryo and you get -- from the bone marrow and other areas of -- body.
-- excitement is how you can use these stem cells regenerative medicine to repair tissue get -- it's damaged by things like Parkinson's disease heart attack.
Autoimmune disorders and that's what the focus is -- but true -- adults themselves the bar had been used a bone marrow transplant for instance isn't that stem cells from bone -- that's transferred to a new patient that's right for thirty years we've been using bone marrow transplantation stem cells to repair person's immune system after chemotherapy you're company is -- something different that what you're doing and trying to push it is.
That you take adult stem cells but it actually helps you re generate a part of the organ.
That is disease so it's not organ replacement.
But it's organ regeneration -- -- a particular I think the heart is what you're focusing on its organ repair we want to be able to use these stem cells to repair the heart after you've had a heart attack how can it affect stroke happy defect wounds repair cartilage -- defects after you had a fracture -- What about clinical trials -- are you with that.
Yes so where we're focused in different ways preclinical and clinical and our trials will be here and abroad in China focusing on how to use specific type of adult stem cells.
To treat these different areas.
In the future so we're focused on these cells.
But you're not just talk about that but -- you brought up the issue of China that's actually where your company is putting the a lot of your effort signed just adult stem cell collection.
And China but also you're going into the pharmaceutical business in China generics and particular.
Back to -- why -- why Chinese pharmaceuticals and -- -- felt the same company you know it's great area.
-- -- therapeutic company with traditional pharma and the upside of stem cell based therapy.
So we have the generic business in China and we're expanding our stem cell therapy so that there's a pipeline for advances easing -- -- Do you kind of the regulatory environment is more positive for you in China than here in the United States because of the controversy that -- product at the top of the segment that.
People still understand about the difference in stem cells.
I think it's not that it's.
Easier it's just different in that here we look at stem cells more as a drug the FDA is regulating stem cells whereas in China the Minister of Health they see this more as a therapy -- -- drug.
So we look at -- the drug within yourself and how can you harness this for future use.
All right let's talk about the attention that you yourself have received in the field of -- -- Suzanne Somers.
She wrote a book and -- focused on different doctors that were pioneering techniques that he believed would would change.
The way that that health care is treated in this country held disease is treated in this country.
And when you were interviewed with her you know you basically said that still you feel that the most frustrating part for you with the confusion.
It's right by the public.
People don't understand that you don't have to destroy fetus to get stem cells that we all have stem cells -- the drug within ourselves and we actually have stem cells that are.
Like embryonic stem cells they can become the different cell types for the different organs so it's education and that's where recent contract with the Vatican.
He's being used to help educate people in advance until.
And and I'm happy about that the Vatican is in support of adult stem cell research just obviously not embryonic erupt like I do want to ask you the cost I know that your marketing and selling stem cell.
To the American public what does it cost.
It's 7500 dollars and 750 year for storage -- the way we store is in multiple tubes from multiple uses in the future.
We look at is -- -- insurance so insurance -- -- -- buy insurance so that basically you're collecting.
You're collecting stem cells and other than younger healthy adult person and they story is that it's McDonnell and thinking OK says -- -- -- on our cells can't -- quantity and well we'll see if and we wish all of this is still unproven but certainly fascinating Robin Smith from the us and thank you very much champion had a the company.
Filter by section